Hurtado, M., et al. Next Generation Sequencing and Functional Pathway Analysis to Understand the Mechanism of Action of Copper-Tolfenamic Acid Against Pancreatic Cancer. Process Biochemistry 2020: 89: 155-164
Broto, J. M., et al. Pazopanib for Treatment of Typical Solitary Fibrous Tumours: A Multicentre, Single-arm, Phase 2 Trial. The Lancet 2020;21(3),456-466. https://doi.org/10.1016/s1470-2045(19)30826-5
Coelho-Lima, J., et al. Kinetics Analysis of Circulating microRNAs Unveils Markers of Failed Myocardial Reperfusion. Clinical Chemistry 2020; 66(1):247:256
Schiano, C., et al. Epigenetic-sensitive Pathways in Personalized Therapy of Major Cardiovascular Diseases. Pharmacology and Therapeutics 2020;207, 107514. In Press. https://doi.org/10.1016/j.pharmathera.2020.107514
Hernandez, D. M., et al. IPF pathogenesis is dependent upon TGFβ induction of IGF-1. The Federation of American Societies for Experimental Biology (FASEB Journal) 2020;0(0):1-26
Millstein, J., et al. Partition: a surjective mapping approach for dimensionality reduction. Bioinformatics 2020; 36(3): 676-681.
Finn, R. S., et al. Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Woment with Treatment-Naïve Metastatic Breast Cancer. Clinical Cancer Research | Precision Medicine and Imaging. 2020 Jan 15. 26:110-21. DOI: 10.1158/1078-0432.CCR-19-0751.
Yoon, A. J., et al. MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at thigh-risk for cancer-specific mortality. Head and Neck. 2020; 1-14
Loke, S. Y., et al., A Circulating miRNA Signature for Stratification of Breast Lesions among Women with Abnormal Screening Mammograms. Cancers - MDPI 2019 Dec.;11(12):1872.
Godoy, P., et al. Comparison of Reproducibility, accuracy, Sensitivity and Specificity of miRNA Quantification Platforms. Cell Reports. 2019 Dec. 17; (29) 4212-4222.
Younes, A., et al. Journal of Clinical Oncology 2019 Mar22;37(15):1285-1295. Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Kargl, J., et al. Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC. Journal of Clinical Investigation Insight 2019;4(24): e130850. https://doig.org/10.1172/jci.insight.130850.
Page last updated March 30, 2020